PureTech to showcase deupirfenidone programme at American Thoracic Society International Conference from May 15-20, 2026: Boston Friday, May 15, 2026, 18:00 Hrs [IST] PureTech Hea ...
All of this can make it difficult for people with IPF to get consistent nutrition and maintain a healthy weight. Rather than eating three large meals a day, you may find that smaller, more frequent ...
Phase 2a data show zero cough and 60% lower treatment-related diarrhea than placebo despite higher nintedanib use in the active arm – suggesting ...
Novel targets aim to stop lung scarring—where current drugs only slow it—while improving tolerability and unlocking fibrosis ...
Completed follow-on common stock offering with net proceeds of ~$162 million, extending expected cash runway into 2030 through potential FDA ...
"Idiopathic Pulmonary Fibrosis Pipeline Insight"There are 80+ key companies, including Bristol-Myers Squibb, Genentech, Tvardi Therapeutics, Melius Pharma, Resproly, and others, developing therapies ...
In this episode of Denatured, you'll be hearing from Georg Vo Beiske, CEO of Tribune Therapeutics and Jonas Hallén, ...
The use of corticosteroids is linked to a higher risk for mortality in patients with acute exacerbations of idiopathic ...
Consultant respiratory physician Professor Peter George answers key questions on the diagnosis and management of pulmonary fibrosis and interstitial lung disease. Complete the module on Pulse 365 ...
Daewoong Pharmaceutical announced on May 6 that it has completed patient enrollment for the global Phase 2 clinical trial ...
DeVona shares how her husband Tim fought for years with pulmonary fibrosis, including two double lung transplants, and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results